Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
By M. D. de Kraker, A. Stewardson, S. Harbarth. PLoS Medicine, 2016
1,351 citations recorded by the source corpus.
Marlieke de Kraker and colleagues reflect on the need for better global estimates for the burden of antimicrobial resistance.
Subfields: Applied Microbiology and Biotechnology, Epidemiology, Health, Toxicology and Mutagenesis
View Paper: https://www.semanticscholar.org/paper/bdb4d0a07e58e15500472b2e5afd506f8d83e086
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In Epidemiology
In Health, Toxicology and Mutagenesis
Citations in the corpus
- Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis (2017, methodology): “This methodology has several biases and has been criticized (47).”
- A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery (2019, background): “It is estimated that by 2050, the death rate due to AMR will balloon to 10 million lives per year at an expense of one hundred trillion dollars [1,2].”